NIFTY50 lost 6% in September: Coal India, Adani Ports, Dr Reddy’s gain up to 13% this month; here's why

Stocks like Coal India, Dr Reddy’s Laboratories, and Adani Ports & SEZ gained up to the tune of around 13% in the month of September 2026, while the benchmark NIFTY50 index lost a little over 6% this month due to several key headwinds and subdued investors sentiment in equities.

NSE data showed that the NIFTY50 index has declined 6.06% this month, ending at 22,620.45 points after the trading session on September 30, as investors focused on the foreign outflows amid the cautious sentiment in the market.

After the final trading day of the month, NIFTY50 closed at 22,620.45 points on Wednesday, in comparison to 22,716.20 points at the previous equity market close.

This week the US benchmark Treasury yields hitting multi-year highs, elevated crude oil prices, and US President Donald Trump rejecting Iran’s peace proposal amid the West Asia conflict kept investors on edge powering the volatility in the market.

Data showed that Brent crude oil prices have surged more than 17% in the month of September as concerns regained among commodity investors with the supply of energy in question amid no signs of re-opening the Strait of Hormuz.

Stocks which gained up to 13% in September

Coal India

As of the final trading close on Sept. 30, Coal India shares outpaced the index performance gaining nearly 6% in one month as investors focused on the production supply growth, latest corporate updates and deals.

NSE data showed that Coal India shares closed flat after the trading session on Wednesday, Sept. 30, with no change at ₹425 apiece.

Investors were focused on Coal India’s improving outlook based on the production growth and supplies at a time when power plants gradually moving towards pre-monsoon levels.

Latest updates showed that Coal India’s major coal-producing subsidiary, Northern Coalfields recorded a 67% rise in overall production and a 75% increase in supply as of September 8, in comparison to the average of Sept 1 to Sept 3.

“At the CIL level, average daily coal production rose by 40%, from an average of 1.36 Million Tonne (MT) per day during the first three rain-affected days of September to 1.91 MT on September 8, 2026,” said Coal India in an official statement.

As of the company’s last update, Northern Coalfields’ total coal production stood at 51.43 million tonnes (MT) in the financial year 2026-27, while its supplies reached 55 MT till Sept 8, marking a significant recovery from the operational challenges posed by heavy rainfall.

Coal India also signed a non-binding memorandum of understanding (MoU) with Hindustan Urvarak & Rasayan Limited to explore the development of a Coal Gasification-based Urea Production at Sindri, Jharkhand.

Dr Reddy’s Laboratories

Pharmaceutical major, Dr Reddy’s Laboratories shares have delivered around 7% returns in the last one-month period, outperforming the benchmark NIFTY50 index which ended on a negative note as of September 30.

NSE data showed that Dr Reddy’s shares closed 1.51% lower at ₹1,233 apiece after the trading session on Wednesday, in comparison to ₹1,251.90 apiece at the previous equity market close.

In September, Dr Reddy’s entered into an agreement with Takeda Biopharmaceuticals India Private Limited to carry out the distribution and marketing of Qdenga® in the private market in India.

With this partnership, the company aims to strengthen its vaccines business in India and supports broader public health efforts aimed at addressing the significant burden of dengue in India.

Latest updates also showed that this month, the company also expanded its collaboration with Gilead Sciences through voluntary licensing agreement for investigational once-yearly lenacapavir for HIV prevention.

Along with the positive updates momentum, investors also focused on the growth potential of the sector amid defensive trading in the market. Market experts predict that rising demand, increased affordability, and innovation opportunities, among other factors, are expected to support the longer-term outlook for the broader healthcare sector.

Dr Reddy’s informed the investors that the company’s board of directors is set to hold its meeting on Friday, October 23, 2026, to consider and approve the unaudited standalone and consolidated financial results of the company for the quarter ending on September 30, 2026.

Adani Ports & SEZ

Adani Ports & SEZ shares have gained nearly 13% in the last one month period, significantly outperforming the benchmark NIFTY50 index as investors kept Adani Group stocks in focus after a settlement deal with SEBI.

NSE data showed that Adani Ports shares closed 1.3% lower at ₹1,798.30 apiece after the trading session on Wednesday, in comparison to ₹1,822 apiece at the previous equity market close.

Earlier this week, Adani Group entities settled proceedings initiated by markets regulator SEBI over alleged violations of minimum public shareholding (MPS) norms by paying a settlement amount of ₹1.48 crore.

In an exchange filing, Adani Ports disclosed that the company paid ₹37,05,000 as the settlement amount to the markets regulator.

At the beginning of the month, Adani Ports received a LOA for development and operations of two dry bulk berths at Paradip Port, Odisha. The company has been awarded this order for a 30-year concession period through a competitive bidding process.

Stock performance